Physical Activity and Exercise

Managing CMR - Managing Cardiometabolic Risk in Abdominally Obese Patients

—THIS EBOOK IS UNDER REVISION—

Key Points

  • Physical inactivity is the most common cardiometabolic risk factor and the easiest one to eliminate.
  • Up to 60 minutes of moderate-intensity endurance exercise on most days of the week can significantly reduce abdominal fat, visceral fat in particular (~30%).
  • Both an acute bout of exercise and chronic endurance exercise can significantly improve insulin sensitivity. The effect is equal to or greater than that achieved with pharmacotherapy (~20% improvement with acute and 30-85% improvement with chronic exercise).
  • Regular endurance exercise can lead to modest but significant improvements in HDL cholesterol (~5%) and triglyceride (~15%) levels. It has less of an effect on LDL cholesterol levels. The lack of change in LDL cholesterol may be misleading, as physical activity can produce a beneficial increase in LDL particle size from small to large.
  • While regular, moderate-intensity endurance exercise can reduce the risk of cardiovascular events by improving an individual’s hemostatic and fibrinolytic profile, intense acute exercise may trigger myocardial infarction, especially in at-risk individuals, by inducing a hypercoaguable state.
  • Endurance exercise has consistently been shown to modestly reduce both systolic and diastolic blood pressure by ~4 mmHg in lean, overweight, hypertensive, and normotensive patients.
  • Although acute exercise can cause elevated systemic inflammation, regular endurance exercise of fairly vigorous intensity appears to reduce levels of inflammatory markers by ~30%.
  • Although the metabolic improvements achieved through regular endurance exercise are generally greater when body weight is reduced, increasing physical activity can dramatically improve visceral fat, insulin resistance, lipid levels, and blood pressure, even when body weight does not change.

Exercise and Cardiometabolic Risk

In the past 20 years, awareness has increased of the complex relationship between individual metabolic abnormalities and subsequent risk of cardiovascular disease (CVD) and type 2 diabetes. Yet our knowledge of this relationship is not new. In 1923, a common clustering of risk factors including obesity, hypertension, and gout had already been described [1]. However, it was not until Reaven’s 1988 Banting lecture [2] that the combination of insulin resistance, dyslipidemia, and hypertension was proposed as a unique entity (syndrome X) that increased CVD and diabetes risk. In addition, based on the early observations of Vague [3,4], others recognized the key role of fat distribution, excess abdominal fat in particular, as a mediator of metabolic risk and component of the syndrome [5]. Over the years, the cluster of obesity [particularly abdominal obesity], insulin resistance, hypertension, and dyslipidemia has been given a variety of names, including syndrome X [2], the deadly quartet [5], dysmetabolic syndrome [6], insulin resistance syndrome [7], and more. Major organizations such as the World Health Organization (WHO) [8] and others [9-11] have recently adopted the term “metabolic syndrome” for clinical diagnostic purposes. Although metabolic syndrome clinical criteria and cutoff values vary between organizations, they often include the following: 1) elevated waist circumference, waist-to-hip ratio, or body mass index, 2) elevated triglycerides, 3) low HDL cholesterol levels, 4) elevated blood pressure, and 5) impaired fasting glucose or glucose intolerance [8-11].

A joint statement by the American Diabetes Association (ADA)and the European Association for the Study of Diabetes [EASD] challenged the concept of the metabolic syndrome and questioned its clinical utility above and beyond individual risk factors [12]. The statement also concluded that “the metabolic syndrome has been imprecisely defined, there is a lack of certainty regarding its pathogenesis, and there is considerable doubt regarding its value as a CVD risk marker” [12]. Following the publication of the critical review of the metabolic syndrome, the International Chair on Cardiometabolic Risk [13], the ADA, and the American Heart Association [AHA] introduced the concept of global cardiometabolic risk, which goes beyond the earlier meaning of the metabolic syndrome to encompass a broader cluster of risk factors associated with CVD and type 2 diabetes [14]. Cardiometabolic risk includes the features of the metabolic syndrome as well as traditional CVD risk factors [13]. Among Canadian adults, physical inactivity is the most prevalent cause of abdominal obesity and the metabolic syndrome [15], and along with smoking is one of the factors that is easiest to target. In addition, physical activity and/or exercise have consistently been recommended for the reduction of many individual cardiometabolic risk factors [9,10,16]. Prospective studies have shown that increasing physical activity seems to protect against the development of diabetes and CVD in a dose-response manner [17,18]. Exercise’s specific role in reducing abdominal obesity, visceral fat in particular, and improving insulin sensitivity, lipid levels (triglycerides, HDL cholesterol, LDL size), blood pressure, thrombosis, and inflammation is examined below.

Although the terms physical activity and exercise are often used interchangeably, a distinction has been made between them for the purposes of this document. Physical activity is defined as any bodily movement produced by skeletal muscles resulting in increased energy expenditure. It includes both occupational and leisure-time physical activity. Exercise is a component of leisure-time physical activity that is planned, structured, repetitive, and performed for the purpose of improving or maintaining physical fitness. While the evidence presented here mainly addresses the effects of structured and regular exercise, it is well established that increasing physical activity during leisure and non-leisure time yields significant benefits [19].

Exercise and Abdominal Obesity

It has been suggested that abdominal obesity, especially visceral obesity, may be a central component of cardiometabolic risk that is linked to many other individual risk factors [20]. According to recent reviews [21,22], regular exercise appears to readily reduce abdominal and visceral obesity. This evidence is presented below.

The literature suggests that regular exercise causes a wide range of visceral fat changes, from a minor reduction of approximately 5% [23] up to a 50% reduction [24]. These changes in visceral fat also produce a wide range of reductions in body weight. Generally, the highest levels of exercise induce the highest energy deficit, which causes greater weight loss and a greater reduction in visceral fat. For example, approximately 60 minutes of daily exercise over three months is associated with a 1.0 and 0.7 kg (-28 and -26%) reduction in visceral fat and a 7.7 and 6.6 kg weight loss in obese men and women, respectively [25,26]. Approximately 20 to 25 minutes of daily exercise was reported to reduce visceral fat by only 6 to 10%, which corresponded with a modest weight loss (1.4 to 1.8 kg) in overweight women [23] and obese women with diabetes [27]. Illustrating a dose-response relationship between exercise dose, weight loss, and visceral fat loss, Irwin et al. [23] found that women who were highly active (>28 min/day) lost 6.9% of their visceral fat, compared to a 5.9% loss among intermediate active women (19 to 28 min/day), a 3.4% loss in low active women (≤18 min/day), and a 0.1% gain in controls over a year-long intervention.

While weight loss remains the hopeful outcome of chronic exercise in overweight individuals, evidence suggests that even when body weight is unchanged, regular exercise can markedly reduce abdominal fat [25,26,28]. For example, approximately two months of regular, moderate-intensity aerobic exercise significantly reduced visceral fat (-41 to -45%) despite there being no change in weight in samples of type 2 diabetics [29,30]. Even non-obese premenopausal women experienced a significant reduction in visceral fat (-25%) in response to six months of aerobic exercise despite no significant change in weight [31]. Several studies have specifically examined the effect of regular exercise on abdominal adiposity when weight is maintained by having study participants consume compensatory kilocalories equivalent to the amount expended during exercise in an effort to maintain weight [25,26,28]. The length of each intervention was roughly three months, with an energy expenditure of approximately 3,500 kcal/wk. The main findings suggest that in obese Caucasian men and women and men with type 2 diabetes, exercise training can significantly reduce total and abdominal obesity even though there may be little or no change in body weight.

While weight loss remains the hopeful outcome of chronic exercise in overweight individuals, evidence suggests that even when body weight is unchanged, regular exercise can markedly reduce abdominal fat [25,26,28]. For example, approximately two months of regular, moderate-intensity aerobic exercise significantly reduced visceral fat (-41 to -45%) despite there being no change in weight in samples of type 2 diabetics [29, 30]. Even non-obese premenopausal women experienced a significant reduction in visceral fat (-25%) in response to six months of aerobic exercise despite no significant change in weight [31]. Several studies have specifically examined the effect of regular exercise on abdominal adiposity when weight is maintained by having study participants consume compensatory kilocalories equivalent to the amount expended during exercise in an effort to maintain weight [25,26,28]. The length of each intervention was roughly three months, with an energy expenditure of approximately 3,500 kcal/wk. The main findings suggest that in obese Caucasian men and women and men with type 2 diabetes, exercise training can significantly reduce total and abdominal obesity even though there may be little or no change in body weight.

Exercise and Insulin Resistance

Insulin resistance has traditionally been cited as the common soil for development of both type 2 diabetes and CVD, and it has been regarded as a key component of cardiometabolic risk [2,32]. The role of insulin resistance in the development of impaired glucose tolerance and overt type 2 diabetes is well established [33,34]. Fortunately, both an acute exercise bout and/or chronic aerobic exercise training have been shown to significantly improve insulin sensitivity and thereby reduce risk of diabetes [35].

Acute Exercise and Insulin Resistance
A single exercise session has been shown to significantly reduce plasma glucose [36,37] and insulin [37] levels in type 2 diabetic subjects. Significant improvements in glucose clearance, as assessed through a euglycemic-hyperinsulinemic clamp, have been achieved in obese diabetics and normoglycemics after one hour of moderate-intensity treadmill exercise [38], insulin-resistant subjects after 50 minutes of moderate-intensity stair climbing exercise [39], diabetic subjects after glycogen-depleting cycle exercise [40], and healthy subjects after 60 minutes of moderate-intensity ergometer exercise [41]. Not only is insulin sensitivity enhanced immediately after the acute exercise bout (38), it appears to last 20 hours after exercise [40] and even up to 48 hours post exercise [39,41], finally dissipating five days post exercise [41]. The degree of improvement in insulin-stimulated whole-body glucose disposal after a single exercise bout ranges from 15 [41) to 24% [38]. These improvements are equal to those achieved through chronic pharmacological intervention [42,43].

Muscle is the main site of insulin-stimulated glucose disposal [44], and the transport of glucose across the plasma membrane appears to be key for glucose disposal in healthy [45] and diabetic [46] subjects. Glucose diffuses into the muscle through glucose transporter proteins (of which GLUT4 is the main isoform), which are translocated to the muscle membrane upon stimulation by insulin [47]. It has been shown that insulin stimulation in diabetic subjects fails to induce normal GLUT4 protein translocation to the muscle membrane [48], thereby limiting glucose diffusion into the muscle. Given this, one potential mechanism underlying enhanced glucose disposal after an acute bout of exercise may be increased translocation of GLUT4 into the sarcolemma and T-tubules of the muscle. Indeed, a single one-hour session of moderate-intensity cycling has been shown to increase the amount of GLUT4 protein in the muscle membrane by almost 75% in a sample of type 2 diabetics and similarly in healthy subjects [49]. Exactly why GLUT4 translocation to the muscle membrane is enhanced post exercise is unclear, but the effect may be due to muscle contraction [50], hypoxia [51], or others [52].

Chronic Endurance Exercise and Insulin Resistance
In addition to the acute effect of exercise, repeated bouts of exercise over an extended period of time appear to cause even bigger improvements in insulin sensitivity. Several excellent reviews have examined the mechanisms behind these exercise-induced improvements in insulin sensitivity [35,53] and suggested a reduction in body fat, visceral fat in particular [25], or increased expression of GLUT4 protein skeletal muscle [54,55].

Approximately three to four months of daily aerobic exercise training inducing a 6 to 8% body weight reduction was shown to improve insulin sensitivity (as assessed by the euglycemic-hyperinsulinemic clamp) by 32 and 60% in middle-aged women and men, respectively [25,26]. In addition, among sedentary and overweight men and women who underwent one of three different exercise interventions 1) low volume/moderate intensity, 2) low volume/high intensity, and 3) high volume/high intensity), all groups experienced significant improvements in insulin sensitivity [56]. While the improvement was lower in the low volume/high intensity group (40%) compared to the other two groups (85%) [56], various combinations of exercise duration and intensity performed on a regular basis will significantly improve insulin sensitivity, and the magnitude of these changes are, on average, greater than those observed after a single exercise bout.

Numerous studies have also shown that chronic exercise can improve insulin sensitivity even without significant weight loss [25,27,57,58]. For example, three months of daily aerobic training in obese men who consumed compensatory kilocalories equivalent to the amount expended during exercise caused a 30% improvement in insulin sensitivity despite no change in weight [25].

The results of the Diabetes Prevention Program have shown that, over a three-year period, a lifestyle modification program featuring a minimum of 150 minutes of exercise per week can reduce the incidence of type 2 diabetes by 58% in at-risk individuals [59]. These results are consistent with other findings [60] and suggest that exercise can prevent diabetes in predisposed patients by improving insulin sensitivity and enhancing glucose disposal acutely and chronically, possibly to a greater degree than what can be achieved through pharmacological interventions [59].

Exercise and Atherogenic Dyslipidemia

The atherogenic lipid profile (or lipid triad) consisting of hypertriglyceridemia, low levels of HDL cholesterol, and high levels of small and dense LDL particles in particular (61) has been tied to other cardiometabolic risk factors such as abdominal obesity [62] and insulin resistance [63]. Accordingly, this cluster of lipid abnormalities has been shown to predict cardiovascular-related morbidity and mortality [64]. Numerous reviews [65-69] and meta-analyses [7,10,70] have investigated the role of exercise in improving dyslipidemia, and the results are summarized below.

The evidence for exercise-related improvements in lipid status appears to be strongest for HDL cholesterol and triglycerides [65,66,67,70,71]. For example, a meta-analysis of 15 randomized, controlled studies revealed that 30 to 60 minutes of moderate-intensity aerobic exercise three to five times per week produced a mean increase in HDL cholesterol levels of ~4% (0.05 mmol/l) and a decrease in triglyceride levels of ~12% (0.21 mmol/l) [71]. These results generally agree with those of a prior review that concluded that aerobic exercise inducing an energy expenditure of 1,200 to 2,200 kcal/wk can increase HDL cholesterol levels by 4 to 22% (0.05-0.21 mmol/l) and decrease triglyceride levels 4 to 37% (0.01-0.43 mmol/l) [66]. Other analyses [67,70] have echoed these findings, suggesting that only a modest amount of exercise is required to produce significant improvements. However, a dose-response relationship has yet to be established [67]. While some studies have suggested that exercise-induced weight loss is necessary to see lipid improvements [65], others have shown that while HDL cholesterol and triglyceride improvements are generally greater in those who lose weight, these improvements can occur even when weight remains virtually unchanged [66,71,72]. However, these changes may depend on changes to body composition, such as increased skeletal muscle mass or reduced visceral fat [25,26].

While post-exercise improvements in HDL cholesterol and triglyceride levels are reported fairly consistently (as reviewed above), there is scant evidence to suggest that exercise significantly reduces LDL cholesterol levels [65,66,67,70,71]. However, while many authors have concluded that exercise rarely has any effect on LDL cholesterol levels [66,71], some have noted a modest (3%) reduction in response to increased physical activity [67]. High numbers of small, dense LDL particles have been shown to predict incidence of CVD independent of total LDL cholesterol levels [73]. Importantly, exercise has been shown to reduce the concentration of small, dense LDL particles and increase mean LDL particle size without altering total LDL cholesterol levels [72]. Exercise may therefore improve morbidity risk without altering LDL cholesterol levels.

Apolipoprotein B is the apolipoprotein moiety of the atherogenic lipoproteins and represents all non-HDL cholesterol (namely VLDL, IDL, and LDL) in circulation [74]. A number of studies have shown that apolipoprotein B levels predict CVD and related events independent of traditional risk factors [75], including the established lipid risk factors described above [76,77]. Accordingly, some suggest the use of apolipoprotein B in lieu of traditional lipid markers (i.e., LDL cholesterol) for predicting vascular disease [78]. Cross-sectional studies suggest that individuals who are most active tend to have the lowest apolipoprotein B levels [79, 80]. In addition, a number of exercise intervention studies have shown that exercise [81-83] and exercise combined with caloric restriction [84,85] can significantly reduce apolipoprotein B levels. These reductions range from 7 to 20% or 0.10 to 0.20 g/l, and the response to exercise appears to be greater among those with elevated baseline triglyceride concentrations [86].

Exercise and Elevated Blood Pressure

High blood pressure has been shown to cause stroke, coronary heart disease, and renal disease, and its reduction is associated with a significant drop in the risk of cardiovascular-related morbidity and mortality [87]. Some have also suggested that blood pressure need not drop dramatically to significantly lower associated health risk [88]. Inactivity is a major risk factor for high blood pressure, and sedentary individuals are up to 50% more likely to develop hypertension compared to more active individuals [89]. Many reviews [90-95] have looked at the effect of regular exercise on blood pressure, and their findings are presented below.

The evidence appears to be quite consistent regarding the ability of regular aerobic exercise to lower blood pressure [90-95]. Exercise has been shown to reduce both systolic and diastolic blood pressure in lean [90,95], obese [90,95], hypertensive [90,93,94], and normotensive [90,91,93] subjects. Some have also suggested that exercise may have a greater anti-hypertensive effect in women than in men [94,96]. Also, any exercise-related reduction in blood pressure may be greater in Asian than in Caucasian subjects [90]. Although modest weight loss (3 to 9%) has been shown to significantly reduce blood pressure [97], other studies have reported that exercise can significantly improve blood pressure independent of changes to weight [93,95]. With regard to ideal exercise training parameters, most reports have suggested that low- to moderate-intensity exercise is ideal for lowering blood pressure [90,94] and that other exercise program parameters (duration, frequency) generally do not have any impact on the level of improvement [90,95,98].

Regular aerobic exercise is known to reduce blood pressure [90-95]. However, the degree of change reported has been inconsistent. For example, a large meta-analysis of 54 randomized, controlled trials found that aerobic exercise reduces systolic and diastolic blood pressure by approximately 4 and 3 mmHg, respectively [90]. These results agree with some findings [91,92,95], are slightly lower than other findings (6 to 7 mmHg reduction in both systolic and diastolic blood pressure) [93], and are significantly lower than the 11 and 8 mmHg reductions in systolic and diastolic blood pressure attributed to aerobic exercise in another review [94]. These minor discrepancies notwithstanding, exercise can be said to cause a modest reduction in blood pressure. Though physical activity will reduce blood pressure, this decrease is rarely significant enough to return blood pressure to normal levels [96].

Exercise and Thrombosis

Thrombosis (the formation of a blood clot in an intact blood vessel) is a key precursor to stroke, myocardial infarction, and other overt symptoms of blood flow obstruction throughout the circulatory system [99]. While physical inactivity is a major risk factor for thrombosis, an acute bout of strenuous exercise has been reported to cause a prothrombotic state and predispose sedentary and at-risk individuals to cardiovascular events [99,100]. A number of investigations and reviews [99-101] have examined the relationship between acute and chronic exercise. Their findings as well as various hemostatic and fibrinolytic factors that contribute to thrombosis are summarized below.

An acute bout of heavy exercise has long been known as a potential trigger for myocardial infarction [102]. Although there are discrepancies in the literature, a prior systematic review concluded that acute exercise can trigger a cardiovascular event by inducing a prothrombotic state associated with abnormal fibrinolysis and augmented platelet aggregation [99]. However, a number of factors can influence the effect of acute exercise on thrombosis, such as baseline fitness and exercise intensity [99]. For example, a number of studies [103,104] have shown that while acute moderate-intensity (55-65% VO2max) exercise can improve fibrinolysis and reduce platelet adhesiveness and aggregation, high intensity (80% VO2max) exercise can have the opposite effect by increasing blood coagulation and platelet adhesion and aggregation. In addition, while the enhanced fibrinolytic response due to acute exercise is highly transient, the hypercoaguable state appears to be more persistent post exercise, providing an ideal environment for clot formation [105].

Conversely, cross-sectional studies [106,107] consistently document the antithrombotic effect of chronic exercise, which lowers fibrinogen levels (and related coaguability) and increases fibrinolytic capacity (also seen after acute exercise). Numerous exercise intervention studies have also documented enhanced fibrinolytic capacity after regular exercise training, as indicated by an increase in tissue plasminogen activator (a fibrolytic stimulator) and a decrease in plasminogen activator inhibitor type 1 (PAI-1) [108-110]. Regular, moderate-intensity endurance exercise also appears to suppress platelet adhesiveness and aggregation, both at rest and following acute intense exercise [110-112]. However, these thrombotic factors quickly revert to pretraining values upon cessation of chronic exercise training [111,112], suggesting that regular exercise must be maintained for its antithrombotic effects to last.

Overall, it seems that while regular, moderate-intensity exercise can reduce the risk of cardiovascular events by improving an individual’s hemostatic and fibrinolytic profile, intense acute exercise may trigger myocardial infarction, especially in at-risk individuals, by inducing a hypercoaguable state [99,100]. These findings account for the apparent paradox between chronic and acute exercise and thrombosis [113] and provide further support for regular, moderate-intensity exercise as a means to prevent cardiovascular events.

Exercise and Systemic Inflammation

Systemic inflammation has recently been recognized as a common thread linking various cardiometabolic risk factors, including insulin resistance, obesity, and dyslipidemia [114,115]. For example, low-grade systemic inflammation has been tied to diabetes [116] and the metabolic syndrome [117]. Chronic low-grade inflammation is generally used to describe the slight (2 to 3x) increase in the concentration of pro-inflammatory markers such as C-reactive protein (CRP), tumour necrosis factor-α (TNF-α), and interleukin-6 (IL-6). As the notion of inflammation in relation to cardiometabolic risk is fairly recent, the amount of literature on the effects of exercise on inflammation pales in comparison to that available for more established risk factors, such as insulin resistance (reviewed above).

As might be expected, acute exercise has been shown to increase levels of inflammatory markers, IL-6 in particular (reviewed in [118]). However, numerous cross-sectional studies have documented an inverse relationship between levels of chronic exercise and systemic levels of inflammatory markers [119-122]. The type of exercise also seems to affect inflammation, with joggers and aerobic dancers less likely to have elevated systemic inflammation compared to cyclists, swimmers, and weight-lifters [123] . Exercise intensity moderates exercise’s effect on systemic inflammation and may explain these activity-specific differences, with vigorous exercise appearing to be better than moderate or light exercise at reducing inflammation [124].

Only a few longitudinal studies have examined the effect of exercise training on systemic inflammation [121,125,126,127]. Most [121,125,127] but not all [126] exercise interventions (which ranged in duration from three to nine months) reported significant reductions in inflammation post-intervention. However, exercise-induced improvements in inflammatory status may only be seen in individuals with high levels of inflammatory markers at baseline [127]. For example, five months of exercise training in a large cohort (n=652) of sedentary men and women divided into low, moderate, or high levels of CRP at baseline showed that only the high CRP group experienced a significant reduction in CRP levels [127]. The extent to which inflammatory markers diminish post exercise appears to be around 25 to 35% [121,125,127]. In all, the evidence available suggests that regular exercise of sufficient intensity has anti-inflammatory effects [128].

With approximately half of North Americans currently leading sedentary lifestyles [15,129], physical inactivity is the most prevalent cardiometabolic risk factor. A sedentary lifestyle can lead to the development of many cardiometabolic risk factors, including abdominal obesity, insulin resistance, dyslipidemia, a prothrombotic state, and systemic inflammation. Fortunately, as depicted in the Figure 1, a multitude of intervention studies have shown that regular, moderate-intensity exercise can improve these cardiometabolic risk factors, which suggests that a physically active lifestyle is an ideal strategy to treat cardiometabolic risk and its related consequences.

References

  1. Kylin E. Studien ueber das hypertonie-hyperglykämie-hyperurikämiesyndrom. Zentralblatt Fuer Innere Med 1923; 44: 105-27.

    PubMed ID:
  2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.

    PubMed ID: 3056758
  3. Vague J. La différenciation sexuelle: facteur déterminant des formes de l’obesité. Presse Med 1947; 339-40.

    PubMed ID: 18918084
  4. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.

    PubMed ID: 13282851
  5. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-20.

    PubMed ID: 2662932
  6. Groop L and Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001; 250: 105-20.

    PubMed ID: 11489060
  7. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-22.

    PubMed ID: 1587398
  8. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Geneva: World Health Organization. 1999.

    PubMed ID:
  9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.

    PubMed ID: 11368702
  10. Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.

    PubMed ID: 14744958
  11. Alberti KG, Zimmet P and Shaw J. The metabolic syndrome–a new worldwide definition. Lancet 2005; 366: 1059-62.

    PubMed ID: 16182882
  12. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.

    PubMed ID: 16123508
  13. Després JP and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.

    PubMed ID: 17167477
  14. Eckel RH, Kahn R, Robertson RM, et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care 2006; 29: 1697-9.

    PubMed ID: 16801605
  15. Statistics Canada. Physical Activity, by age group and sex. 2005. http://www40.statcan.ca/l01/cst01/health46.htm, last accessed August 2007.

    PubMed ID:
  16. Grundy SM, Hansen B, Smith SC, Jr., et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-6.

    PubMed ID: 14757684
  17. Kohl HW, 3rd. Physical activity and cardiovascular disease: evidence for a dose response. Med Sci Sports Exerc 2001; 33: S472-83; discussion S93-4.

    PubMed ID: 11427773
  18. Kelley DE and Goodpaster BH. Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus. Med Sci Sports Exerc 2001; 33: S495-501; discussion S28-9.

    PubMed ID: 11427776
  19. Physical activity and health. A report from the surgeon general executive summary. http://www.cdc.gov/nccdphp/sgr/pdf/execsumm.pdf. 1999.

    PubMed ID:
  20. Després JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J 2006; 8: B4-B12.

    PubMed ID:
  21. Janiszewski PM and Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab 2007; 32: 512-22.

    PubMed ID: 17510691
  22. Ross R and Janssen I. Physical activity, total and regional obesity: dose-response considerations. Med Sci Sports Exerc 2001; 33: S521-7; discussion S8-9.

    PubMed ID: 11427779
  23. Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003; 289: 323-30.

    PubMed ID: 12525233
  24. Park SK, Park JH, Kwon YC, et al. The effect of combined aerobic and resistance exercise training on abdominal fat in obese middle-aged women. J Physiol Anthropol Appl Human Sci 2003; 22: 129-35.

    PubMed ID: 12808225
  25. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133: 92-103.

    PubMed ID: 10896648
  26. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12: 789-98.

    PubMed ID: 15166299
  27. Giannopoulou I, Ploutz-Snyder LL, Carhart R, et al. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 1511-8.

    PubMed ID: 15598677
  28. Lee S, Kuk JL, Davidson LE, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol 2005; 99: 1220-5.

    PubMed ID: 15860689
  29. Boudou P, Sobngwi E, Mauvais-Jarvis F, et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003; 149: 421-4.

    PubMed ID: 14585088
  30. Mourier A, Gautier JF, De Kerviler E, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385-91.

    PubMed ID: 9051392
  31. Thomas EL, Brynes AE, McCarthy J, et al. Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 2000; 35: 769-76.

    PubMed ID: 10941878
  32. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 1992; 20 Suppl 11: S1-16.

    PubMed ID: 1284137
  33. DeFronzo RA, Bonadonna RC and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-68.

    PubMed ID: 1532777
  34. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-92.

    PubMed ID: 8247074
  35. Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002; 93: 788-96.

    PubMed ID: 12133893
  36. Larsen JJ, Dela F, Kjaer M, et al. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 1997; 40: 447-53.

    PubMed ID: 9112022
  37. Musi N, Fujii N, Hirshman MF, et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001; 50: 921-7.

    PubMed ID: 11334434
  38. Burstein R, Epstein Y, Shapiro Y, et al. Effect of an acute bout of exercise on glucose disposal in human obesity. J Appl Physiol 1990; 69: 299-304.

    PubMed ID: 2203726
  39. Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-62.

    PubMed ID: 8857019
  40. Devlin JT, Hirshman M, Horton ED, et al. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434-9.

    PubMed ID: 3102297
  41. Mikines KJ, Sonne B, Farrell PA, et al. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988; 254: E248-59.

    PubMed ID: 3126668
  42. Widen EI, Eriksson JG and Groop LC. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 1992; 41: 354-8.

    PubMed ID: 1551495
  43. Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-93.

    PubMed ID: 7935656
  44. Baron AD, Brechtel G, Wallace P, et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 1988; 255: E769-74.

    PubMed ID: 3059816
  45. Fink RI, Wallace P, Brechtel G, et al. Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 1992; 41: 897-902.

    PubMed ID: 1640870
  46. Butler PC, Kryshak EJ, Marsh M, et al. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes 1990; 39: 1373-80.

    PubMed ID:
  47. Shepherd PR and Kahn BB. Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-57.

    PubMed ID: 10413738
  48. Ryder JW, Yang J, Galuska D, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-54.

    PubMed ID: 10871204
  49. Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48: 1192-7.

    PubMed ID: 10331428
  50. Gao J, Ren J, Gulve EA, et al. Additive effect of contractions and insulin on GLUT-4 translocation into the sarcolemma. J Appl Physiol 1994; 77: 1597-601.

    PubMed ID: 7836174
  51. Cartee GD, Douen AG, Ramlal T, et al. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991; 70: 1593-600.

    PubMed ID: 2055841
  52. Etgen GJ, Jr., Fryburg DA and Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 1997; 46: 1915-9.

    PubMed ID: 9356048
  53. Borghouts LB and Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med 2000; 21: 1-12.

    PubMed ID: 10683091
  54. Houmard JA, Shinebarger MH, Dolan PL, et al. Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am J Physiol 1993; 264: E896-901.

    PubMed ID: 8333515
  55. Hughes VA, Fiatarone MA, Fielding RA, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993; 264: E855-62.

    PubMed ID: 8333511
  56. Houmard JA, Tanner CJ, Slentz CA, et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 2004; 96: 101-6.

    PubMed ID: 12972442
  57. Boudou P, De Kerviler E, Vexiau P, et al. Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status. Diabetes Metab 2000; 26: 450-7.

    PubMed ID: 11173715
  58. Dengel DR, Pratley RE, Hagberg JM, et al. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996; 81: 318-25.

    PubMed ID: 8828680
  59. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.

    PubMed ID: 11832527
  60. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.

    PubMed ID: 11333990
  61. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998; 81: 18B-25B.

    PubMed ID: 9526809
  62. Sattar N, Tan CE, Han TS, et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 1998; 22: 432-9.

     

    PubMed ID: 9622340
  63. Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 1998; 47: 1174-9.

    PubMed ID: 9781617
  64. Lehto S, Ronnemaa T, Haffner SM, et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-9.

    PubMed ID: 9231662
  65. Stefanick ML. Physical activity for preventing and treating obesity-related dyslipoproteinemias. Med Sci Sports Exerc 1999; 31: S609-18.

    PubMed ID: 10593536
  66. Durstine JL, Grandjean PW, Davis PG, et al. Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 2001; 31: 1033-62.

    PubMed ID: 11735685
  67. Leon AS and Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001; 33: S502-15; discussion S28-9.

    PubMed ID: 11427777
  68. Després JP and Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implication for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6: 137-59.

    PubMed ID: 19094306
  69. Després JP and Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994; 236: 7-22.

    PubMed ID: 8021576
  70. Halbert JA, Silagy CA, Finucane P, et al. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur J Clin Nutr 1999; 53: 514-22.

    PubMed ID: 10452405
  71. Carroll S and Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med 2004; 34: 371-418.

    PubMed ID: 15157122
  72. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-92.

    PubMed ID: 12421890
  73. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75.

    PubMed ID: 8994419
  74. Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-33.

    PubMed ID: 16030277
  75. Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273-8.

    PubMed ID: 8759066
  76. Lamarche B, Tchernof A, Mauriège P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-61.

    PubMed ID: 9643858
  77. Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005; 112: 3375-83.

    PubMed ID: 16316964
  78. Barter PJ, Ballantyne CM, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006; 259: 247-58.

    PubMed ID: 16476102
  79. Ziogas GG, Thomas TR and Harris WS. Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution. Med Sci Sports Exerc 1997; 29: 986-91.

    PubMed ID: 9268954
  80. Mora S, Lee IM, Buring JE, et al. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006; 295: 1412-9.

    PubMed ID: 16551713
  81. Holme I, Hostmark AT and Anderssen SA. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. J Intern Med 2007; 262: 235-43.

    PubMed ID: 17645591
  82. Alam S, Stolinski M, Pentecost C, et al. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 688-94.

    PubMed ID: 14764782
  83. Ring-Dimitriou S, von Duvillard SP, Paulweber B, et al. Nine months aerobic fitness induced changes on blood lipids and lipoproteins in untrained subjects versus controls. Eur J Appl Physiol 2007; 99: 291-9.

    PubMed ID: 17186304
  84. Halle M, Berg A, Garwers U, et al. Influence of 4 weeks’ intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes. Metabolism 1999; 48: 641-4.

    PubMed ID: 10337867
  85. Janssen I, Fortier A, Hudson R, et al. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002; 25: 431-8.

    PubMed ID: 11874926
  86. Couillard C, Després JP, Lamarche B, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001; 21: 1226-32.

    PubMed ID: 11451756
  87. He J and Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138: 211-9.

    PubMed ID: 10467215
  88. Cook NR, Cohen J, Hebert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995; 155: 701-9.

    PubMed ID: 7695458
  89. Paffenbarger RS, Jr., Wing AL, Hyde RT, et al. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol 1983; 117: 245-57.

    PubMed ID: 6829553
  90. Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.

    PubMed ID: 11926784
  91. Kelley GA. Effects of aerobic exercise in normotensive adults: a brief meta-analytic review of controlled clinical trials. South Med J 1995; 88: 42-6.

    PubMed ID: 7817226
  92. Kelley GA. Aerobic exercise and resting blood pressure among women: a meta-analysis. Prev Med 1999; 28: 264-75.

    PubMed ID: 10072745
  93. Arroll B and Beaglehole R. Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol 1992; 45: 439-47.

    PubMed ID: 1588350
  94. Hagberg JM, Park JJ and Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med 2000; 30: 193-206.

    PubMed ID: 10999423
  95. Fagard RH. Physical activity in the prevention and treatment of hypertension in the obese. Med Sci Sports Exerc 1999; 31: S624-30.

    PubMed ID: 10593538
  96. Eriksson J, Taimela S and Koivisto VA. Exercise and the metabolic syndrome. Diabetologia 1997; 40: 125-35.

    PubMed ID: 9049471
  97. Hermansen K. Diet, blood pressure and hypertension. Br J Nutr 2000; 83 Suppl 1: S113-9.

    PubMed ID: 10889801
  98. Church TS, Earnest CP, Skinner JS, et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 2007; 297: 2081-91.

    PubMed ID: 17507344
  99. Lee KW and Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368-92.

    PubMed ID: 14581258
  100. Koenig W and Ernst E. Exercise and thrombosis. Coron Artery Dis 2000; 11: 123-7.

    PubMed ID: 10758813
  101. El-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32: 918-25.

    PubMed ID: 10795781
  102. Tofler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol 1990; 66: 22-7.

    PubMed ID: 2193495
  103. Weiss C, Welsch B, Albert M, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30: 1205-10.

    PubMed ID: 9710858
  104. Wang JS, Jen CJ, Kung HC, et al. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 1994; 90: 2877-85.

    PubMed ID: 7994833
  105. Hegde SS, Goldfarb AH and Hegde S. Clotting and fibrinolytic activity change during the 1 h after a submaximal run. Med Sci Sports Exerc 2001; 33: 887-92.

    PubMed ID: 11404652
  106. el-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22: 282-98.

    PubMed ID: 8923646
  107. Eliasson M, Asplund K and Evrin PE. Regular leisure time physical activity predicts high activity of tissue plasminogen activator: The Northern Sweden MONICA Study. Int J Epidemiol 1996; 25: 1182-8.

    PubMed ID: 9027522
  108. De Paz JA, Lasierra J, Villa JG, et al. Effects of aerobic and anaerobic physical conditioning on fibrinolysis. J Sports Med Phys Fitness 1995; 35: 263-7.

    PubMed ID: 8776073
  109. Lindahl B, Nilsson TK, Jansson JH, et al. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 1999; 246: 105-12.

    PubMed ID: 10447232
  110. Coppola L, Grassia A, Coppola A, et al. Effects of a moderate-intensity aerobic program on blood viscosity, platelet aggregation and fibrinolytic balance in young and middle-aged sedentary subjects. Blood Coagul Fibrinolysis 2004; 15: 31-7.

    PubMed ID: 15166941
  111. Wang JS, Jen CJ and Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 1995; 15: 1668-74.

    PubMed ID: 7583542
  112. Wang JS, Jen CJ and Chen HI. Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol 1997; 83: 2080-5.

    PubMed ID: 9390984
  113. Thrall G and Lip GY. Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state? Arterioscler Thromb Vasc Biol 2005; 25: 265-6.

    PubMed ID: 15681304
  114. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002; 18: 430-2.

    PubMed ID: 11985951
  115. Dandona P, Aljada A and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7.

    PubMed ID: 14698276
  116. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-805.

    PubMed ID: 12829649
  117. Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-21.

    PubMed ID: 12401749
  118. Petersen AM and Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-62.

    PubMed ID: 15772055
  119. Abramson JL and Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286-92.

    PubMed ID: 12038947
  120. Geffken DF, Cushman M, Burke GL, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 242-50.

    PubMed ID: 11157411
  121. Mattusch F, Dufaux B, Heine O, et al. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000; 21: 21-4.

    PubMed ID: 10683094
  122. Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785-90.

    PubMed ID: 11956120
  123. King DE, Carek P, Mainous AG, 3rd, et al. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 2003; 35: 575-81.

    PubMed ID: 12673139
  124. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002; 13: 561-8.

    PubMed ID: 12192226
  125. Tisi PV, Hulse M, Chulakadabba A, et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14: 344-50.

    PubMed ID: 9413374
  126. Smith JK, Dykes R, Douglas JE, et al. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722-7.

    PubMed ID: 10328073
  127. Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005; 26: 2018-25.

    PubMed ID: 15987707
  128. Das UN. Anti-inflammatory nature of exercise. Nutrition 2004; 20: 323-6.

    PubMed ID: 14990277
  129. Center for Disease Control and Prevention. US physical activity statistics. 2005. http://apps.nccd.cdc.gov/PASurveillance/StateSumResultV.asp?CI=&Year=2005&State=0#data, last accessed August 2007.

    PubMed ID:
Reference 1 CLOSECLOSE

Kylin E. Studien ueber das hypertonie-hyperglykämie-hyperurikämiesyndrom. Zentralblatt Fuer Innere Med 1923; 44: 105-27.

PubMed ID:
Reference 2 CLOSECLOSE

Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.

PubMed ID: 3056758
Reference 3 CLOSECLOSE

Vague J. La différenciation sexuelle: facteur déterminant des formes de l’obesité. Presse Med 1947; 339-40.

PubMed ID: 18918084
Reference 4 CLOSECLOSE

Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.

PubMed ID: 13282851
Reference 5 CLOSECLOSE

Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-20.

PubMed ID: 2662932
Reference 6 CLOSECLOSE

Groop L and Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001; 250: 105-20.

PubMed ID: 11489060
Reference 7 CLOSECLOSE

Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-22.

PubMed ID: 1587398
Reference 8 CLOSECLOSE

Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Geneva: World Health Organization. 1999.

PubMed ID:
Reference 9 CLOSECLOSE

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.

PubMed ID: 11368702
Reference 10 CLOSECLOSE

Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.

PubMed ID: 14744958
Reference 11 CLOSECLOSE

Alberti KG, Zimmet P and Shaw J. The metabolic syndrome–a new worldwide definition. Lancet 2005; 366: 1059-62.

PubMed ID: 16182882
Reference 12 CLOSECLOSE

Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.

PubMed ID: 16123508
Reference 13 CLOSECLOSE

Després JP and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.

PubMed ID: 17167477
Reference 14 CLOSECLOSE

Eckel RH, Kahn R, Robertson RM, et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care 2006; 29: 1697-9.

PubMed ID: 16801605
Reference 15 CLOSECLOSE

Statistics Canada. Physical Activity, by age group and sex. 2005. http://www40.statcan.ca/l01/cst01/health46.htm, last accessed August 2007.

PubMed ID:
Reference 16 CLOSECLOSE

Grundy SM, Hansen B, Smith SC, Jr., et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-6.

PubMed ID: 14757684
Reference 17 CLOSECLOSE

Kohl HW, 3rd. Physical activity and cardiovascular disease: evidence for a dose response. Med Sci Sports Exerc 2001; 33: S472-83; discussion S93-4.

PubMed ID: 11427773
Reference 18 CLOSECLOSE

Kelley DE and Goodpaster BH. Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus. Med Sci Sports Exerc 2001; 33: S495-501; discussion S28-9.

PubMed ID: 11427776
Reference 19 CLOSECLOSE

Physical activity and health. A report from the surgeon general executive summary. http://www.cdc.gov/nccdphp/sgr/pdf/execsumm.pdf. 1999.

PubMed ID:
Reference 20 CLOSECLOSE

Després JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J 2006; 8: B4-B12.

PubMed ID:
Reference 21 CLOSECLOSE

Janiszewski PM and Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab 2007; 32: 512-22.

PubMed ID: 17510691
Reference 22 CLOSECLOSE

Ross R and Janssen I. Physical activity, total and regional obesity: dose-response considerations. Med Sci Sports Exerc 2001; 33: S521-7; discussion S8-9.

PubMed ID: 11427779
Reference 23 CLOSECLOSE

Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003; 289: 323-30.

PubMed ID: 12525233
Reference 24 CLOSECLOSE

Park SK, Park JH, Kwon YC, et al. The effect of combined aerobic and resistance exercise training on abdominal fat in obese middle-aged women. J Physiol Anthropol Appl Human Sci 2003; 22: 129-35.

PubMed ID: 12808225
Reference 25 CLOSECLOSE

Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133: 92-103.

PubMed ID: 10896648
Reference 26 CLOSECLOSE

Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12: 789-98.

PubMed ID: 15166299
Reference 27 CLOSECLOSE

Giannopoulou I, Ploutz-Snyder LL, Carhart R, et al. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 1511-8.

PubMed ID: 15598677
Reference 28 CLOSECLOSE

Lee S, Kuk JL, Davidson LE, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol 2005; 99: 1220-5.

PubMed ID: 15860689
Reference 29 CLOSECLOSE

Boudou P, Sobngwi E, Mauvais-Jarvis F, et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003; 149: 421-4.

PubMed ID: 14585088
Reference 30 CLOSECLOSE

Mourier A, Gautier JF, De Kerviler E, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385-91.

PubMed ID: 9051392
Reference 31 CLOSECLOSE

Thomas EL, Brynes AE, McCarthy J, et al. Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 2000; 35: 769-76.

PubMed ID: 10941878
Reference 32 CLOSECLOSE

DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 1992; 20 Suppl 11: S1-16.

PubMed ID: 1284137
Reference 33 CLOSECLOSE

DeFronzo RA, Bonadonna RC and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-68.

PubMed ID: 1532777
Reference 34 CLOSECLOSE

Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-92.

PubMed ID: 8247074
Reference 35 CLOSECLOSE

Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002; 93: 788-96.

PubMed ID: 12133893
Reference 36 CLOSECLOSE

Larsen JJ, Dela F, Kjaer M, et al. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 1997; 40: 447-53.

PubMed ID: 9112022
Reference 37 CLOSECLOSE

Musi N, Fujii N, Hirshman MF, et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001; 50: 921-7.

PubMed ID: 11334434
Reference 38 CLOSECLOSE

Burstein R, Epstein Y, Shapiro Y, et al. Effect of an acute bout of exercise on glucose disposal in human obesity. J Appl Physiol 1990; 69: 299-304.

PubMed ID: 2203726
Reference 39 CLOSECLOSE

Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-62.

PubMed ID: 8857019
Reference 40 CLOSECLOSE

Devlin JT, Hirshman M, Horton ED, et al. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434-9.

PubMed ID: 3102297
Reference 41 CLOSECLOSE

Mikines KJ, Sonne B, Farrell PA, et al. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988; 254: E248-59.

PubMed ID: 3126668
Reference 42 CLOSECLOSE

Widen EI, Eriksson JG and Groop LC. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 1992; 41: 354-8.

PubMed ID: 1551495
Reference 43 CLOSECLOSE

Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-93.

PubMed ID: 7935656
Reference 44 CLOSECLOSE

Baron AD, Brechtel G, Wallace P, et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 1988; 255: E769-74.

PubMed ID: 3059816
Reference 45 CLOSECLOSE

Fink RI, Wallace P, Brechtel G, et al. Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 1992; 41: 897-902.

PubMed ID: 1640870
Reference 46 CLOSECLOSE

Butler PC, Kryshak EJ, Marsh M, et al. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes 1990; 39: 1373-80.

PubMed ID:
Reference 47 CLOSECLOSE

Shepherd PR and Kahn BB. Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-57.

PubMed ID: 10413738
Reference 48 CLOSECLOSE

Ryder JW, Yang J, Galuska D, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-54.

PubMed ID: 10871204
Reference 49 CLOSECLOSE

Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48: 1192-7.

PubMed ID: 10331428
Reference 50 CLOSECLOSE

Gao J, Ren J, Gulve EA, et al. Additive effect of contractions and insulin on GLUT-4 translocation into the sarcolemma. J Appl Physiol 1994; 77: 1597-601.

PubMed ID: 7836174
Reference 51 CLOSECLOSE

Cartee GD, Douen AG, Ramlal T, et al. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991; 70: 1593-600.

PubMed ID: 2055841
Reference 52 CLOSECLOSE

Etgen GJ, Jr., Fryburg DA and Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 1997; 46: 1915-9.

PubMed ID: 9356048
Reference 53 CLOSECLOSE

Borghouts LB and Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med 2000; 21: 1-12.

PubMed ID: 10683091
Reference 54 CLOSECLOSE

Houmard JA, Shinebarger MH, Dolan PL, et al. Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am J Physiol 1993; 264: E896-901.

PubMed ID: 8333515
Reference 55 CLOSECLOSE

Hughes VA, Fiatarone MA, Fielding RA, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993; 264: E855-62.

PubMed ID: 8333511
Reference 56 CLOSECLOSE

Houmard JA, Tanner CJ, Slentz CA, et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 2004; 96: 101-6.

PubMed ID: 12972442
Reference 57 CLOSECLOSE

Boudou P, De Kerviler E, Vexiau P, et al. Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status. Diabetes Metab 2000; 26: 450-7.

PubMed ID: 11173715
Reference 58 CLOSECLOSE

Dengel DR, Pratley RE, Hagberg JM, et al. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996; 81: 318-25.

PubMed ID: 8828680
Reference 59 CLOSECLOSE

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.

PubMed ID: 11832527
Reference 60 CLOSECLOSE

Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.

PubMed ID: 11333990
Reference 61 CLOSECLOSE

Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998; 81: 18B-25B.

PubMed ID: 9526809
Reference 62 CLOSECLOSE

Sattar N, Tan CE, Han TS, et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 1998; 22: 432-9.

 

PubMed ID: 9622340
Reference 63 CLOSECLOSE

Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 1998; 47: 1174-9.

PubMed ID: 9781617
Reference 64 CLOSECLOSE

Lehto S, Ronnemaa T, Haffner SM, et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-9.

PubMed ID: 9231662
Reference 65 CLOSECLOSE

Stefanick ML. Physical activity for preventing and treating obesity-related dyslipoproteinemias. Med Sci Sports Exerc 1999; 31: S609-18.

PubMed ID: 10593536
Reference 66 CLOSECLOSE

Durstine JL, Grandjean PW, Davis PG, et al. Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 2001; 31: 1033-62.

PubMed ID: 11735685
Reference 67 CLOSECLOSE

Leon AS and Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001; 33: S502-15; discussion S28-9.

PubMed ID: 11427777
Reference 68 CLOSECLOSE

Després JP and Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implication for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6: 137-59.

PubMed ID: 19094306
Reference 69 CLOSECLOSE

Després JP and Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994; 236: 7-22.

PubMed ID: 8021576
Reference 70 CLOSECLOSE

Halbert JA, Silagy CA, Finucane P, et al. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur J Clin Nutr 1999; 53: 514-22.

PubMed ID: 10452405
Reference 71 CLOSECLOSE

Carroll S and Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med 2004; 34: 371-418.

PubMed ID: 15157122
Reference 72 CLOSECLOSE

Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-92.

PubMed ID: 12421890
Reference 73 CLOSECLOSE

Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75.

PubMed ID: 8994419
Reference 74 CLOSECLOSE

Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-33.

PubMed ID: 16030277
Reference 75 CLOSECLOSE

Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273-8.

PubMed ID: 8759066
Reference 76 CLOSECLOSE

Lamarche B, Tchernof A, Mauriège P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-61.

PubMed ID: 9643858
Reference 77 CLOSECLOSE

Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005; 112: 3375-83.

PubMed ID: 16316964
Reference 78 CLOSECLOSE

Barter PJ, Ballantyne CM, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006; 259: 247-58.

PubMed ID: 16476102
Reference 79 CLOSECLOSE

Ziogas GG, Thomas TR and Harris WS. Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution. Med Sci Sports Exerc 1997; 29: 986-91.

PubMed ID: 9268954
Reference 80 CLOSECLOSE

Mora S, Lee IM, Buring JE, et al. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006; 295: 1412-9.

PubMed ID: 16551713
Reference 81 CLOSECLOSE

Holme I, Hostmark AT and Anderssen SA. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. J Intern Med 2007; 262: 235-43.

PubMed ID: 17645591
Reference 82 CLOSECLOSE

Alam S, Stolinski M, Pentecost C, et al. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 688-94.

PubMed ID: 14764782
Reference 83 CLOSECLOSE

Ring-Dimitriou S, von Duvillard SP, Paulweber B, et al. Nine months aerobic fitness induced changes on blood lipids and lipoproteins in untrained subjects versus controls. Eur J Appl Physiol 2007; 99: 291-9.

PubMed ID: 17186304
Reference 84 CLOSECLOSE

Halle M, Berg A, Garwers U, et al. Influence of 4 weeks’ intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes. Metabolism 1999; 48: 641-4.

PubMed ID: 10337867
Reference 85 CLOSECLOSE

Janssen I, Fortier A, Hudson R, et al. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002; 25: 431-8.

PubMed ID: 11874926
Reference 86 CLOSECLOSE

Couillard C, Després JP, Lamarche B, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001; 21: 1226-32.

PubMed ID: 11451756
Reference 87 CLOSECLOSE

He J and Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138: 211-9.

PubMed ID: 10467215
Reference 88 CLOSECLOSE

Cook NR, Cohen J, Hebert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995; 155: 701-9.

PubMed ID: 7695458
Reference 89 CLOSECLOSE

Paffenbarger RS, Jr., Wing AL, Hyde RT, et al. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol 1983; 117: 245-57.

PubMed ID: 6829553
Reference 90 CLOSECLOSE

Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.

PubMed ID: 11926784
Reference 91 CLOSECLOSE

Kelley GA. Effects of aerobic exercise in normotensive adults: a brief meta-analytic review of controlled clinical trials. South Med J 1995; 88: 42-6.

PubMed ID: 7817226
Reference 92 CLOSECLOSE

Kelley GA. Aerobic exercise and resting blood pressure among women: a meta-analysis. Prev Med 1999; 28: 264-75.

PubMed ID: 10072745
Reference 93 CLOSECLOSE

Arroll B and Beaglehole R. Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol 1992; 45: 439-47.

PubMed ID: 1588350
Reference 94 CLOSECLOSE

Hagberg JM, Park JJ and Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med 2000; 30: 193-206.

PubMed ID: 10999423
Reference 95 CLOSECLOSE

Fagard RH. Physical activity in the prevention and treatment of hypertension in the obese. Med Sci Sports Exerc 1999; 31: S624-30.

PubMed ID: 10593538
Reference 96 CLOSECLOSE

Eriksson J, Taimela S and Koivisto VA. Exercise and the metabolic syndrome. Diabetologia 1997; 40: 125-35.

PubMed ID: 9049471
Reference 97 CLOSECLOSE

Hermansen K. Diet, blood pressure and hypertension. Br J Nutr 2000; 83 Suppl 1: S113-9.

PubMed ID: 10889801
Reference 98 CLOSECLOSE

Church TS, Earnest CP, Skinner JS, et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 2007; 297: 2081-91.

PubMed ID: 17507344
Reference 99 CLOSECLOSE

Lee KW and Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368-92.

PubMed ID: 14581258
Reference 100 CLOSECLOSE

Koenig W and Ernst E. Exercise and thrombosis. Coron Artery Dis 2000; 11: 123-7.

PubMed ID: 10758813
Reference 101 CLOSECLOSE

El-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32: 918-25.

PubMed ID: 10795781
Reference 102 CLOSECLOSE

Tofler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol 1990; 66: 22-7.

PubMed ID: 2193495
Reference 103 CLOSECLOSE

Weiss C, Welsch B, Albert M, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30: 1205-10.

PubMed ID: 9710858
Reference 104 CLOSECLOSE

Wang JS, Jen CJ, Kung HC, et al. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 1994; 90: 2877-85.

PubMed ID: 7994833
Reference 105 CLOSECLOSE

Hegde SS, Goldfarb AH and Hegde S. Clotting and fibrinolytic activity change during the 1 h after a submaximal run. Med Sci Sports Exerc 2001; 33: 887-92.

PubMed ID: 11404652
Reference 106 CLOSECLOSE

el-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22: 282-98.

PubMed ID: 8923646
Reference 107 CLOSECLOSE

Eliasson M, Asplund K and Evrin PE. Regular leisure time physical activity predicts high activity of tissue plasminogen activator: The Northern Sweden MONICA Study. Int J Epidemiol 1996; 25: 1182-8.

PubMed ID: 9027522
Reference 108 CLOSECLOSE

De Paz JA, Lasierra J, Villa JG, et al. Effects of aerobic and anaerobic physical conditioning on fibrinolysis. J Sports Med Phys Fitness 1995; 35: 263-7.

PubMed ID: 8776073
Reference 109 CLOSECLOSE

Lindahl B, Nilsson TK, Jansson JH, et al. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 1999; 246: 105-12.

PubMed ID: 10447232
Reference 110 CLOSECLOSE

Coppola L, Grassia A, Coppola A, et al. Effects of a moderate-intensity aerobic program on blood viscosity, platelet aggregation and fibrinolytic balance in young and middle-aged sedentary subjects. Blood Coagul Fibrinolysis 2004; 15: 31-7.

PubMed ID: 15166941
Reference 111 CLOSECLOSE

Wang JS, Jen CJ and Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 1995; 15: 1668-74.

PubMed ID: 7583542
Reference 112 CLOSECLOSE

Wang JS, Jen CJ and Chen HI. Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol 1997; 83: 2080-5.

PubMed ID: 9390984
Reference 113 CLOSECLOSE

Thrall G and Lip GY. Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state? Arterioscler Thromb Vasc Biol 2005; 25: 265-6.

PubMed ID: 15681304
Reference 114 CLOSECLOSE

Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002; 18: 430-2.

PubMed ID: 11985951
Reference 115 CLOSECLOSE

Dandona P, Aljada A and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7.

PubMed ID: 14698276
Reference 116 CLOSECLOSE

Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-805.

PubMed ID: 12829649
Reference 117 CLOSECLOSE

Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-21.

PubMed ID: 12401749
Reference 118 CLOSECLOSE

Petersen AM and Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-62.

PubMed ID: 15772055
Reference 119 CLOSECLOSE

Abramson JL and Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286-92.

PubMed ID: 12038947
Reference 120 CLOSECLOSE

Geffken DF, Cushman M, Burke GL, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 242-50.

PubMed ID: 11157411
Reference 121 CLOSECLOSE

Mattusch F, Dufaux B, Heine O, et al. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000; 21: 21-4.

PubMed ID: 10683094
Reference 122 CLOSECLOSE

Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785-90.

PubMed ID: 11956120
Reference 123 CLOSECLOSE

King DE, Carek P, Mainous AG, 3rd, et al. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 2003; 35: 575-81.

PubMed ID: 12673139
Reference 124 CLOSECLOSE

Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002; 13: 561-8.

PubMed ID: 12192226
Reference 125 CLOSECLOSE

Tisi PV, Hulse M, Chulakadabba A, et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14: 344-50.

PubMed ID: 9413374
Reference 126 CLOSECLOSE

Smith JK, Dykes R, Douglas JE, et al. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722-7.

PubMed ID: 10328073
Reference 127 CLOSECLOSE

Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005; 26: 2018-25.

PubMed ID: 15987707
Reference 128 CLOSECLOSE

Das UN. Anti-inflammatory nature of exercise. Nutrition 2004; 20: 323-6.

PubMed ID: 14990277
Reference 129 CLOSECLOSE

Center for Disease Control and Prevention. US physical activity statistics. 2005. http://apps.nccd.cdc.gov/PASurveillance/StateSumResultV.asp?CI=&Year=2005&State=0#data, last accessed August 2007.

PubMed ID: